🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

29 recruiting trials

for Gene Mutation-Related Cancer

PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas NCT06961565Phase 15 sites📍 Birmingham📍 St Leonards📍 Melbourne Pasithea Therapeutics Corp. · Tests: PAS-004 Tablets Impact of Environmental Exposures on Tumor Risk in SDHx-mutation Carriers NCT06408402n/a20 sites📍 Angers📍 Besançon📍 Bron Assistance Publique - Hôpitaux de Paris Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia NCT05512169n/a2 sites📍 New Delhi📍 Puducherry University of Geneva, Switzerland Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic Cholestasis NCT06781242n/a2 sites📍 Bologna📍 Modena IRCCS Azienda Ospedaliero-Universitaria di Bologna An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results NCT05420064NA8 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: Intervention Arm At-risk Relative/ARR Contacts, MyGene Portal, Standard of Care DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study NCT01247597n/a2 sites📍 Bethesda📍 Rockville National Cancer Institute (NCI) Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL NCT07154043NA1 site📍 Denizli Pamukkale University · Tests: Complete Decongestive Therapy (CDT), CDT + Intermittent Pneumatic Compression (IPC), CDT without Manual Lymph Drainage … XL092 and Cemiplimab in BRAF WT Thyroid Cancer NCT06902376Phase 12 sites📍 Boston📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Cemiplimab, XL092 NEROFE and Doxorubicin in KRAS-mutated ST2-positive Solid Tumors NCT05661201Phase 11 site📍 Washington D.C. Georgetown University · Tests: NEROFE, Doxorubicin Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours. NCT07148128Phase 1, Phase 24 sites📍 Dallas📍 San Antonio📍 Toronto Auricula Biosciences Inc. · Tests: WEF-001 Personalized NK Cell Therapy in CBT NCT02727803Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Allogeneic Natural Killer Cell Line NK-92, Anti-Thymocyte Globulin, Busulfan, Clofarabine, Cyclophosphamide Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight NCT01238250n/a2 sites📍 Boston📍 Lewisburg Simons Searchlight Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies NCT05786924Phase 1, Phase 249 sites📍 Gilbert📍 Los Angeles📍 Los Angeles Institut de Recherches Internationales Servier · Tests: S241656, FOLFOX6/FOLFOX7, FOLFIRI, Cetuximab, Panitumumab RASopathy Biorepository NCT04395495n/a1 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati Study of Families With an Hemopathies Predisposition Related to the DDX41 Gene. NCT06022016NA5 sites📍 Bordeaux📍 Limoges📍 Marseille Institut Claudius Regaud · Tests: For each person (index case or related) included in this study: Prediction of Germline BRCA 1/2 Genes From Healthy Ovaries NCT05769517n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: Germinal BRCA CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) NCT04151342n/a27 sites📍 Calgary📍 Edmonton📍 Vancouver University Health Network, Toronto · Tests: Cancer treatment with tyrosine kinase inhibitors (TKIs) or other molecularly targeted therapeutic agents., Patient-repo… Genetic Information Assistant in Telegenetics NCT06089421NA1 site📍 Charlottesville University of Virginia · Tests: Genetic Information Assistant, Telegenetics with UVA genetic counselor A Retrospective Study of EGFR-TKIs,Gefitinib, Erlotinib and Osimertinib in NSCLC Patients Treatment NCT01994057n/a1 site📍 Guangzhou Sun Yat-sen University COsegregation of VARiants in Panel of Genes NCT01689584NA62 sites📍 Bastia📍 Saint-Cloud📍 Amiens Institut Curie · Tests: salivary kit A Phase 1/1b Study of IAM1363 in HER2 Cancers NCT06253871Phase 153 sites📍 La Jolla📍 Los Angeles📍 Aurora Iambic Therapeutics, Inc · Tests: IAM1363 PRE-ISPY Phase I/II Oncology Platform Program NCT05868226Phase 1, Phase 210 sites📍 Birmingham📍 Phoenix📍 Aurora QuantumLeap Healthcare Collaborative · Tests: ALX148, Fam-Trastuzumab Deruxtecan-Nxki, Zanidatamab, Tucatinib, TTX-MC138 Determining Individualized Cancer Therapy in Pancreatic Cancer NCT05914987n/a1 site📍 Milwaukee Medical College of Wisconsin · Tests: Targeted Therapy EQUAL: EGFR ctDNA QUantative Assessment for Lung Cancer Screening in Asian and Latinx Populations NCT06716580NA6 sites📍 Boston📍 Boston📍 Boston Dana-Farber Cancer Institute · Tests: Circulating Tumor DNA (ctDNA) Assay Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors NCT06625775Phase 144 sites📍 Duarte📍 Los Angeles📍 San Diego TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) · Tests: BBO-10203, Trastuzumab, Fulvestrant, Ribociclib, FOLFOX A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations NCT05983159Phase 22 sites📍 Parkville📍 Parkville Murdoch Childrens Research Institute · Tests: Alpelisib, Mirdametinib Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies NCT07064018Phase 1, Phase 21 site📍 Orange University of California, Irvine · Tests: Spedox-6, Pegfilgrastim, Filgrastim Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT NCT07589413n/a1 site📍 Lanzhou Zhiping Wang · Tests: Measurement of Intraoperative Irrigation Fluid Absorption and Perioperative cfDNA Profiling
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy